tazarotene has been researched along with Genetic Predisposition in 3 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daroach, M | 1 |
| Dogra, S | 1 |
| Bhattacharjee, R | 1 |
| Tp, A | 1 |
| Smith, F | 1 |
| Mahajan, R | 1 |
| So, PL | 1 |
| Lee, K | 1 |
| Hebert, J | 1 |
| Walker, P | 1 |
| Lu, Y | 1 |
| Hwang, J | 1 |
| Kopelovich, L | 1 |
| Athar, M | 1 |
| Bickers, D | 1 |
| Aszterbaum, M | 1 |
| Epstein, EH | 1 |
| Cotellessa, C | 1 |
| Cuevas-Covarrubias, SA | 1 |
| Valeri, P | 1 |
| Fargnoli, MC | 1 |
| Peris, K | 1 |
1 review available for tazarotene and Genetic Predisposition
| Article | Year |
|---|---|
Pachyonychia congenita responding favorably to a combination of surgical and medical therapies.
Topics: Administration, Topical; Combined Modality Therapy; Female; Genetic Predisposition to Disease; Human | 2019 |
2 other studies available for tazarotene and Genetic Predisposition
| Article | Year |
|---|---|
Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.
Topics: Administration, Topical; Animals; Anticarcinogenic Agents; Carcinoma, Basal Cell; Female; Genetic Pr | 2004 |
Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.
Topics: Administration, Cutaneous; Adult; Dermatologic Agents; Diagnosis, Differential; Epilepsy; Genetic Pr | 2005 |